- Home
- NRXP vs CLPS Comparison
NRXP vs CLPS Comparison
Compare NRXP & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CLPS
- Stock Information
- Founded
- NRXP 2015
- CLPS 2005
- Country
- NRXP United States
- CLPS Hong Kong
- Employees
- NRXP N/A
- CLPS N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- NRXP Health Care
- CLPS Technology
- Exchange
- NRXP Nasdaq
- CLPS Nasdaq
- Market Cap
- NRXP 58.5M
- CLPS 26.9M
- IPO Year
- NRXP N/A
- CLPS 2018
- Fundamental
- Price
- NRXP $2.85
- CLPS $0.92
- Analyst Decision
- NRXP Strong Buy
- CLPS
- Analyst Count
- NRXP 4
- CLPS 0
- Target Price
- NRXP $28.50
- CLPS N/A
- AVG Volume (30 Days)
- NRXP 137.7K
- CLPS 11.0K
- Earning Date
- NRXP 08-13-2025
- CLPS 03-05-2025
- Dividend Yield
- NRXP N/A
- CLPS 13.71%
- EPS Growth
- NRXP N/A
- CLPS N/A
- EPS
- NRXP N/A
- CLPS N/A
- Revenue
- NRXP N/A
- CLPS $153,816,045.00
- Revenue This Year
- NRXP N/A
- CLPS N/A
- Revenue Next Year
- NRXP $230.95
- CLPS N/A
- P/E Ratio
- NRXP N/A
- CLPS N/A
- Revenue Growth
- NRXP N/A
- CLPS 5.81
- 52 Week Low
- NRXP $1.10
- CLPS $0.68
- 52 Week High
- NRXP $6.01
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- NRXP 38.54
- CLPS 42.16
- Support Level
- NRXP $2.89
- CLPS $0.92
- Resistance Level
- NRXP $3.15
- CLPS $1.00
- Average True Range (ATR)
- NRXP 0.14
- CLPS 0.05
- MACD
- NRXP -0.04
- CLPS -0.00
- Stochastic Oscillator
- NRXP 10.22
- CLPS 15.32
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.